BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36906951)

  • 1. SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression.
    Wang M; Ding Y; Hu Y; Li Z; Luo W; Liu P; Li Z
    Redox Biol; 2023 Jun; 62():102652. PubMed ID: 36906951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
    You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
    Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
    Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
    Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
    Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y
    Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
    Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
    Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
    Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3.
    Wang M; Li J; Ding Y; Cai S; Li Z; Liu P
    Eur J Pharmacol; 2021 Sep; 906():174283. PubMed ID: 34174269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
    Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
    Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
    Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis.
    Peng F; Liao M; Jin W; Liu W; Li Z; Fan Z; Zou L; Chen S; Zhu L; Zhao Q; Zhan G; Ouyang L; Peng C; Han B; Zhang J; Fu L
    Signal Transduct Target Ther; 2024 May; 9(1):133. PubMed ID: 38744811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure.
    Qian K; Tang J; Ling YJ; Zhou M; Yan XX; Xie Y; Zhu LJ; Nirmala K; Sun KY; Qin ZH; Sheng R
    EBioMedicine; 2023 Dec; 98():104863. PubMed ID: 37950995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT3 regulates cardiolipin biosynthesis in pressure overload-induced cardiac remodeling by PPARγ-mediated mechanism.
    Liu LX; Zheng XH; Hai JH; Zhang CM; Ti Y; Chen TS; Bu PL
    PLoS One; 2024; 19(4):e0301990. PubMed ID: 38625851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SIRT3-ATAD3A axis regulates MAM dynamics and mitochondrial calcium homeostasis in cardiac hypertrophy.
    Li Z; Hu O; Xu S; Lin C; Yu W; Ma D; Lu J; Liu P
    Int J Biol Sci; 2024; 20(3):831-847. PubMed ID: 38250153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity.
    Jin L; Geng L; Ying L; Shu L; Ye K; Yang R; Liu Y; Wang Y; Cai Y; Jiang X; Wang Q; Yan X; Liao B; Liu J; Duan F; Sweeney G; Woo CWH; Wang Y; Xia Z; Lian Q; Xu A
    Circulation; 2022 Nov; 146(20):1537-1557. PubMed ID: 36134579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in mitochondrial dynamics with age-related Sirtuin1/Sirtuin3 deficiency impair cardiomyocyte contractility.
    Zhang J; He Z; Fedorova J; Logan C; Bates L; Davitt K; Le V; Murphy J; Li M; Wang M; Lakatta EG; Ren D; Li J
    Aging Cell; 2021 Jul; 20(7):e13419. PubMed ID: 34216536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3.
    Pillai VB; Samant S; Sundaresan NR; Raghuraman H; Kim G; Bonner MY; Arbiser JL; Walker DI; Jones DP; Gius D; Gupta MP
    Nat Commun; 2015 Apr; 6():6656. PubMed ID: 25871545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress.
    Tomczyk MM; Cheung KG; Xiang B; Tamanna N; Fonseca Teixeira AL; Agarwal P; Kereliuk SM; Spicer V; Lin L; Treberg J; Tong Q; Dolinsky VW
    Circ Heart Fail; 2022 May; 15(5):e008547. PubMed ID: 35418250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway.
    Peng S; Lu XF; Qi YD; Li J; Xu J; Yuan TY; Wu XY; Ding Y; Li WH; Zhou GQ; Wei Y; Li J; Chen SW; Liu SW
    Oxid Med Cell Longev; 2020; 2020():9815039. PubMed ID: 33014281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling.
    Gao J; Zhang K; Wang Y; Guo R; Liu H; Jia C; Sun X; Wu C; Wang W; Du J; Chen J
    Pharmacol Res; 2020 May; 155():104739. PubMed ID: 32135248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.